175 related articles for article (PubMed ID: 23422885)
1. Association between preprocedural hemoglobin level and 1-year outcome of elective percutaneous coronary intervention.
Hosseini SK; Ansari MJ; Lotfi Tokaldany M; Sharafi A; Hakki Kazazi E; Poorhosseini H
J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):331-5. PubMed ID: 23422885
[TBL] [Abstract][Full Text] [Related]
2. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization.
Nusca A; Patti G; Marino F; Mangiacapra F; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2012 Sep; 80(3):377-84. PubMed ID: 21681905
[TBL] [Abstract][Full Text] [Related]
4. Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.
Faggioni M; Baber U; Sartori S; Chandrasekhar J; Cohen DJ; Henry TD; Claessen BE; Dangas GD; Gibson CM; Krucoff MW; Vogel B; Moliterno DJ; Sorrentino S; Colombo A; Chieffo A; Kini A; Farhan S; Ariti C; Witzenbichler B; Weisz G; Steg PG; Pocock S; Mehran R
Circ Cardiovasc Interv; 2019 Apr; 12(4):e007133. PubMed ID: 30998384
[TBL] [Abstract][Full Text] [Related]
5. Relation of Preprocedural Hemoglobin Level to Outcomes After Percutaneous Coronary Intervention.
Kim BG; Kim H; Hong SJ; Ahn CM; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y; Kim BK; Lee BK
Am J Cardiol; 2019 Nov; 124(9):1319-1326. PubMed ID: 31493827
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention.
Kitai Y; Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Yanagita M; Shizuta S; Kimura T;
Int J Cardiol; 2013 Oct; 168(6):5221-8. PubMed ID: 23998544
[TBL] [Abstract][Full Text] [Related]
7. [Anemia as an independent predictor of poor long-term outcomes after percutaneous coronary intervention].
Liu XM; Kang JP; Lü Q; Liu XH; Wu XS; Ma CS
Zhonghua Nei Ke Za Zhi; 2008 Feb; 47(2):114-6. PubMed ID: 18683796
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin nonrecovery following acute myocardial infarction is a biomarker of poor outcome: a retrospective database study.
Leshem-Rubinow E; Steinvil A; Rogowski O; Zeltser D; Berliner S; Weitzman D; Raz R; Chodick G; Shalev V
Int J Cardiol; 2013 Nov; 169(5):349-53. PubMed ID: 24182909
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in patients with renal impairment undergoing percutaneous coronary intervention and implantation of the Endeavor zotarolimus-eluting stent: 1- and 2-year data from the E-Five Registry.
Rothman MT; Jain AK;
Catheter Cardiovasc Interv; 2012 Nov; 80(6):885-92. PubMed ID: 22517785
[TBL] [Abstract][Full Text] [Related]
10. Anemia before coronary artery bypass surgery as additional risk factor increases the perioperative risk.
Boening A; Boedeker RH; Scheibelhut C; Rietzschel J; Roth P; Schönburg M
Ann Thorac Surg; 2011 Sep; 92(3):805-10. PubMed ID: 21592459
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention.
McKechnie RS; Smith D; Montoye C; Kline-Rogers E; O'Donnell MJ; DeFranco AC; Meengs WL; McNamara R; McGinnity JG; Patel K; Share D; Riba A; Khanal S; Moscucci M;
Circulation; 2004 Jul; 110(3):271-7. PubMed ID: 15226214
[TBL] [Abstract][Full Text] [Related]
12. Anemia as independent predictor of major events in elderly patients with chronic angina.
Muzzarelli S; Pfisterer M;
Am Heart J; 2006 Nov; 152(5):991-6. PubMed ID: 17070178
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
[TBL] [Abstract][Full Text] [Related]
14. Anemia is an independent predictor of mortality after percutaneous coronary intervention.
Lee PC; Kini AS; Ahsan C; Fisher E; Sharma SK
J Am Coll Cardiol; 2004 Aug; 44(3):541-6. PubMed ID: 15358017
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
[TBL] [Abstract][Full Text] [Related]
16. Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting.
Bertrand OF; Larose E; Rodés-Cabau J; Rinfret S; Déry JP; Bagur R; Gleeton O; Nguyen CM; Proulx G; De Larochellière R; Poirier P; Costerousse O; Roy L
Am J Cardiol; 2010 Jul; 106(2):155-61. PubMed ID: 20598996
[TBL] [Abstract][Full Text] [Related]
17. Low hemoglobin concentration is associated with poor outcome after peripheral arterial surgery.
Oshin OA; Torella F
Vasc Endovascular Surg; 2013 Aug; 47(6):449-53. PubMed ID: 23794093
[TBL] [Abstract][Full Text] [Related]
18. Impact of Anemia and Dual Antiplatelet Therapy on Mortality in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents.
Wang H; Yang Y; Ma L; Wang X; Zhang J; Fu J; Zhang S; Zhang L; Hu D; Ding R
Sci Rep; 2015 Nov; 5():17213. PubMed ID: 26601689
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
20. Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.
Harjai KJ; Kondareddy S; Pinkosky B; Harjai N; Orshaw P; Boura J
J Interv Cardiol; 2013 Apr; 26(2):153-62. PubMed ID: 23363439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
